Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/
You can print this page and show it to your doctor.

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.

ProPublica's Dollars for Docs database lets you search for payments to U.S.-based doctors made by pharmaceutical and medical device companies between August 2013 and December 2018. The disclosure of these payments is required under the Physician Payments Sunshine Act, a provision of the 2010 Affordable Care Act.


About This Information

  • The information that appears here comes directly from the federal government. Companies must attest to its accuracy, and doctors have the ability to contest information they believe is in error.
  • This site includes payments for such activities as speaking, consulting, meals, travel and royalties. It does not include payments for clinical research.
  • It is legal for companies to make payments to doctors as long as the payments are not a kickback or inducement to use their products.
  • Some doctors say collaborative relationships, particularly those involving research, are necessary to develop new treatments and cures. But many ethicists have raised questions about the payments, and studies show that they may influence doctors' prescribing decisions.
  • Only you can decide if this matters to you and if so, whether you want to talk with your doctor about it. If you plan to talk with your doctor (or if you already have), please help us by filling out this short survey: propub.li/participate-d4d

Preparing for Your Conversation

If you decide you'd like to talk to your doctor about this, please keep in mind:

  • Many health care professionals in our database have similar names, so you should start by asking your doctor if the person mentioned in this payment record is really him/her.
  • Your doctor may not know he or she is listed as receiving payments, especially if the payments are small. You can direct your doctor to this site (the URL will be printed at the top of the payment record) or directly to the government's site here: https://openpaymentsdata.cms.gov/physician/209026
  • Some doctors are happy to discuss this information with you. Others might not be. The best approach is to ask questions and to not be accusatory.

Questions You Might Want to Ask

  • Is this you?
  • What type of work do you do with these companies?
  • Have you prescribed me any drugs that are manufactured by companies you've taken payments from?
  • Are there non-drug alternatives that I may want to consider first?
  • Are there less expensive generic alternatives to the drugs you have prescribed?
  • What devices have you used in my care that are manufactured by companies you've taken payments from?

Dollars for Docs: Talk With Your Doctor

https://projects.propublica.org/docdollars/doctors/pid/209026
If you spot an error, please let us know at [email protected].

This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.


ROBIN DORE

Listed Specialty: Rheumatology
12791 NEWPORT AVE, SUITE 201, TUSTIN, CA, 92780-2751

2018 Payments: At a Glance

600

payments

$360,169

payment total

26

companies paid this doctor

Types of Payments

Category Payments Payment Value
Promotional Speaking/Other
113 $203K
Consulting
33 $95,298
Travel and Lodging
118 $41,023
Food and Beverage
325 $13,152
Honoraria
5 $7,965
Education
6 $164

Drugs & Devices in 2018

Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.

Product Name Product Type Payments
Payments with no listed product

N/A

$129K
COSENTYX

drug

$58,028
ENBREL

drug

$46,942
XELJANZ

drug

$21,452
KEVZARA

drug

$17,481
TYMLOS

drug

$13,201
TALTZ

drug

$12,625
FORTEO

drug

$11,987
OTEZLA

drug

$9,182
STRENSIQ

drug

$8,898
CIMZIA

drug

$8,157
DUZALLO

drug

$8,010
PROLIA

drug

$5,494
HUMIRA

drug

$4,723
ORENCIA

drug

$3,699
SIMPONI ARIA

drug

$309
ACTEMRA

drug

$136
RITUXAN

drug

$136
ACTHAR

drug

$110
KRYSTEXXA

drug

$91
† May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products.

For ease of printing, only the 20 drugs and devices with the highest payments are displayed. For a complete list, please visit: https://projects.propublica.org/docdollars/doctors/pid/209026

Payment Details

When How Much Related To What For From Third Party Payee
Oct 12, 2018 $7,050 COSENTYX Consulting NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
Nov 26, 2018 $6,825 No Listed Product Consulting LILLY USA, LLC ROBIN K DORE MD INC
Feb 9, 2018 $6,300 ENBREL Consulting AMGEN INC. ROBIN K DORE MD INC
May 9, 2018 $6,300 No Listed Product Consulting LILLY USA, LLC ROBIN K DORE MD INC
Nov 30, 2018 $5,535 COSENTYX Consulting NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
Apr 13, 2018 $5,400 TYMLOS Promotional Speaking/Other RADIUS HEALTH, INC.
Jun 13, 2018 $5,050 COSENTYX Consulting NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
Feb 9, 2018 $4,988 TALTZ Consulting LILLY USA, LLC ROBIN K DORE MD INC
Jan 24, 2018 $4,988 No Listed Product Consulting LILLY USA, LLC ROBIN K DORE MD INC
Aug 2, 2018 $4,725 No Listed Product Consulting LILLY USA, LLC ROBIN K DORE MD INC
Dec 14, 2018 $4,200 No Listed Product Consulting LILLY USA, LLC ROBIN K DORE MD INC
Jan 13, 2018 $4,040 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
May 10, 2018 $4,040 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
Apr 12, 2018 $4,040 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION ROBIN K DORE MD INC
Aug 18, 2018 $4,040 COSENTYX Promotional Speaking/Other NOVARTIS PHARMACEUTICALS CORPORATION
Sep 28, 2018 $4,000 No Listed Product Consulting AMGEN INC. ROBIN K DORE MD INC
Nov 28, 2018 $3,500 CIMZIA Promotional Speaking/Other UCB, INC.
Jun 6, 2018 $3,454 KEVZARA Promotional Speaking/Other GENZYME CORPORATION Robin K. Dore, MD Inc
Jun 6, 2018 $3,454 KEVZARA Promotional Speaking/Other GENZYME CORPORATION Robin K. Dore, MD Inc
Mar 12, 2018 $3,413 FORTEO Consulting LILLY USA, LLC ROBIN K DORE MD INC

For ease of printing, 20 payments are displayed, the largest appearing on top. For a full list of payments, please visit: https://projects.propublica.org/docdollars/doctors/pid/209026

Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].

This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.